Hyaluronan in inflammatory joint disease

References

• Gäre Andersson B., Fasth A. Serum concentration of hyaluronan, IgM and IgA rheumatoid factors in a population based study of juvenile chronic arthritis. Scand J Rheumatol 1994; 23: 183–90
   PubMed Web of Science ®Google Scholar
• Antonas K N., Fraser J R E, Muirden K D. Distribution of biologically labelled radioactive hyaluronic acid injected into joints. Ann Rheum Dis 1973; 32: 103–11
   PubMed Web of Science ®Google Scholar
• Balazs E A., Watson D, Duff I F., Roseman S. Hyaluronic acid in synovial fluid. Molecular parameters of hyaluronic acid in normal and arthritic fluids. Arthr Rheum 1967; 10: 357–76
   PubMed Web of Science ®Google Scholar
• Björk J, Kleinau S, Tengblad A, Smedegård G. Elevated levels of serum hyaluronate and correlation with disease activity in experimental models of arthritis. Arthr Rheum 1989; 32: 306–11
   PubMed Web of Science ®Google Scholar
• Brown T J., Laurent U B G, Fraser J R E. Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol 1991; 76: 125–34
   PubMed Web of Science ®Google Scholar
• Chassagne P, Le Loet X, Delpech B, Levesque H, Menard J F., Maingonnat C, Deshayes P. Étude des variations nycthérmérales du taux sérique d'acide hyaluronique au cours de la polyarthrite rhumatoïde. Rev Rhum 1989; 56: 775–9
   PubMedGoogle Scholar
• Dahl L B., Dahl I M S, Engström-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985; 44: 817–22
   PubMed Web of Science ®Google Scholar
• Dahl L B., Laurent T C., Smedsröd B. Preparation of biologically intact radioiodinated hyaluronan of high specific radioactivity: coupling of 125I-tyramine-cellobiose to amino groups after partial N-deacetylation. Anal Biochem 1988; 175: 397–407
   PubMedGoogle Scholar
• Engström-Laurent A, Hällgren R. Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985; 44: 83–8
   PubMed Web of Science ®Google Scholar
• Engström-Laurent A, Hällgren R. Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Arthr Rheum 1987; 30: 1333–8
   PubMed Web of Science ®Google Scholar
• Engström-Laurent A, Laurent T C. Hyaluronan as a clinical marker. Clinical impact of bone and connective tissue markers, E Lindh, J I. Thorell. Academic Press, London 1989; 235–52
   Google Scholar
• Engström-Laurent A, Laurent U B G, Lilja K, Laurent T C. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 1985; 45: 497–504
   PubMed Web of Science ®Google Scholar
• Fraser J R E, Engström-Laurent A, Nyberg A, Laurent T C. Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis. J Lab Clin Med 1986; 107: 79–85
   PubMed Web of Science ®Google Scholar
• Fraser J R E, Kimpton W G., Laurent T C., Cahill R N P, Vakakis N. Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 1988; 256: 153–8
   PubMed Web of Science ®Google Scholar
• Fraser J R E, Kimpton W G., Pierscionek B K., Cahill R N P. The kinetics of hyaluronan in normal and acutely inflamed synovial joints: observations with experimental arthritis in sheep. Sem Arthr Rheum 1993; 22(Suppl 1)9–17
   PubMedGoogle Scholar
• Fraser J R E, Laurent T C., Pertoft H, Baxter E. Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J 1981; 200: 415–24
   PubMed Web of Science ®Google Scholar
• Goldberg R L., Huff J P., Lenz M E., Glickman P, Katz R, Thonar E J-M A. Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthr Rheum 1991; 34: 799–807
   PubMed Web of Science ®Google Scholar
• Heldin P, Laurent T C., Heldin C-H. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J 1989; 258: 919–22
   PubMed Web of Science ®Google Scholar
• Laurent T C., Fraser J R E. The properties and turnover of hyaluronan. In: Functions of the proteoglycans. Wiley, Chichester 1986; 9–29, Ciba Found Symp 124
   Google Scholar
• Laurent T C., Fraser J R E. Hyaluronan. FASEB J 1992; 6: 2397–2404
   PubMed Web of Science ®Google Scholar
• Laurent T C., Lilja K, Brunnberg L, Engström-Laurent A, Laurent U B G, Lindqvist U, Murata K, Ytterberg D. Urinary excretion of hyaluronan in man. Scand J Clin Lab Invest 1987; 47: 793–9
   PubMed Web of Science ®Google Scholar
• Laurent U B G, Fraser J R E, Engström-Laurent A, Reed R K., Dahl L B., Laurent T C. Catabolism of hyaluronan in the knee joint of the rabbit. Matrix 1992; 12: 130–6
   PubMedGoogle Scholar
• Laurent U B G, Fraser J R E, Laurent T C. An experimental technique to study the turnover of concentrated hyaluronan in the anterior chamber of the rabbit. Exp Eye Res 1988; 46: 49–58
   PubMedGoogle Scholar
• Laurent U B G, Laurent T C. On the origin of hyaluronate in blood Biochem Internat. 1981; 2: 195–9
   Google Scholar
• Levesque H, Delpech B, Le Loet X, Deshayes P. Serum hyaluronate in rheumatoid arthritis: study by affino-immunoenzymatic assay. Br J Rheumatol 1988; 27: 445–9
   PubMedGoogle Scholar
• Lindqvist U, Engström-Laurent A, Laurent U, Nyberg A, Björklund U, Eriksson H, Pettersson R, Tengblad A. The diurnal variation of serum hyaluronan in health and disease. Scand J Clin Lab Invest 1988; 48: 765–70
   PubMed Web of Science ®Google Scholar
• Lindqvist U, Groth T, Lööf L, Hellsing K. A hyaluronan-loading test applied to patients with liver and joint diseases. Clin Chim Acta 1992; 210: 119–32
   PubMed Web of Science ®Google Scholar
• Lindqvist U, Laurent T C. Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. Scand J Clin Lab Invest 1992; 52: 613–21
   PubMed Web of Science ®Google Scholar
• Paimela L, Heiskanen A, Kurki P, Helve T, Leirisalo-Repo M. Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthr Rheum 1991; 34: 815–21
   PubMed Web of Science ®Google Scholar
• Pitsillides A A., Worrall J G., Wilkinson L S., Bayliss M T., Edwards J C W. Hyaluronan concentration in non-inflamed and rheumatoid synovium. Br J Rheum 1994; 33: 5–10
   PubMedGoogle Scholar
• Poole A R., Witter J, Roberts N, Piccolo F, Brandt R, Paquin J, Baron M. Inflammation and cartilage metabolism in rheumatoid arthritis. Arthr Rheum 1990; 33: 790–9
   PubMedGoogle Scholar
• Reed R K., Laurent U B G. Turnover of hyaluronan in the microcirculation. Am Rev Respir Dis 1992; 146: S37–S39
   Google Scholar
• Saari H, Konttinen Y T., Nordström D. Effect of joint mobilization on serum hyaluronate. Ann Med 1991; 23: 29–32
   PubMed Web of Science ®Google Scholar
• Seibel M J., Raimann S, Seglias J, Lautenschläger J, Müller W. Serum-Hyaluronsäure und aminoterminales Prokollagen-III-Peptid bei entzündlichen und degenerativen Gelenkerkrankungen. Z Rheumatol 1988; 47: 98–106
   PubMed Web of Science ®Google Scholar
• Smedsröd B, Pertoft H, Eriksson S, Fraser J R E, Laurent T C. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 1984; 223: 617–26
   PubMed Web of Science ®Google Scholar
• Seppälä P. Synovial fluid in rheumatoid arthritis. University of Turku, Turku 1964, Thesis
   Google Scholar
• Sundblad L. Glycosaminoglycans and glycoproteins in synovial fluid. The amino sugars, E A. Balazs, R W. Jeanloz. Academic Press, New York and London 1965; 2A: 229–50
   Google Scholar
• Wells A F., Klareskog L, Lindblad S, Laurent T C. Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells. Arthr Rheum 1992; 35: 391–6
   PubMedGoogle Scholar
• Worrall J G., Bayliss M T., Edwards J C W. Morphological localization of hyaluronan in normal and diseased synovium. J Rheumatol 1991; 18: 1466–72
   PubMedGoogle Scholar